NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 182 filers reported holding NEVRO CORP in Q2 2022. The put-call ratio across all filers is 1.60 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $17 | +13.3% | 860 | +45.3% | 0.00% | – |
| Q2 2023 | $15 | -28.6% | 592 | +2.2% | 0.00% | – |
| Q1 2023 | $21 | -22.2% | 579 | -15.1% | 0.00% | – |
| Q4 2022 | $27 | -99.9% | 682 | -2.8% | 0.00% | – |
| Q3 2022 | $33,000 | -2.9% | 702 | -10.1% | 0.00% | – |
| Q2 2022 | $34,000 | -38.2% | 781 | +3.2% | 0.00% | – |
| Q1 2022 | $55,000 | +17.0% | 757 | +29.6% | 0.00% | – |
| Q4 2021 | $47,000 | – | 584 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Broadfin Capital, LLC | 622,615 | $38,920,000 | 8.04% |
| Tamarack Advisers, LP | 160,000 | $10,002,000 | 3.97% |
| Birch Run Capital Advisors, LP | 187,425 | $11,716,000 | 3.72% |
| Prosight Management, LP | 128,765 | $8,049,000 | 3.52% |
| Ratan Capital Management LP | 38,653 | $2,416,000 | 3.44% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 579,463 | $36,222,000 | 1.39% |
| Spark Investment Management LLC | 403,400 | $25,216,000 | 1.17% |
| Sivik Global Healthcare LLC | 50,000 | $3,126,000 | 1.15% |
| ArrowMark Colorado Holdings LLC | 1,882,009 | $117,644,000 | 1.11% |
| PFM Health Sciences, LP | 721,229 | $45,084,000 | 1.00% |